Ruosen Xie

Dr. Ruosen Xie

Department of Ophthalmology and Visual Sciences; Wisconsin Institute for Discovery; University of Wisconsin-Madison; Madison, WI 53705, United States
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2022 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
MYMingzhou Ye
Mingzhou Ye
YZYi Zhao
Yi Zhao
YWYuyuan Wang
Yuyuan Wang
Ruosen XieRuosen Xie
Ruosen Xie
YTYao Tong
Yao Tong
SGShaoqin Gong
Shaoqin Gong

17 April 2024 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
JZJingcheng Zhu
Jingcheng Zhu
Ruosen XieRuosen Xie
Ruosen Xie
RGRuixuan Gao
Ruixuan Gao
YZYi Zhao
Yi Zhao
NYNisakorn Yodsanit
Nisakorn Yodsanit
SGShaoqin Gong
Shaoqin Gong

1 August 2017 in Journal of Controlled Release
Verified
Journal Article
Closed access
GCGuojun Chen
Guojun Chen
YWYuyuan Wang
Yuyuan Wang
Ruosen XieRuosen Xie
Ruosen Xie
SGShaoqin Gong
Shaoqin Gong

1 May 2018 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
GCGuojun Chen
Guojun Chen
YWYuyuan Wang
Yuyuan Wang
Ruosen XieRuosen Xie
Ruosen Xie
SGShaoqin Gong
Shaoqin Gong

20 November 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
GCGuojun Chen
Guojun Chen
BMBen Ma
Ben Ma
YWYuyuan Wang
Yuyuan Wang
Ruosen XieRuosen Xie
Ruosen Xie
CLChun Li
Chun Li
SGShaoqin Gong
Shaoqin Gong

23 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
YZYing Zhang
Ying Zhang
RSRaghava N. Sriramaneni
Raghava N. Sriramaneni
PCPaul A. Clark
Paul A. Clark
JJJustin C. Jagodinsky
Justin C. Jagodinsky
MYMingzhou Ye
Mingzhou Ye
ZMZachary S. Morris
Zachary S. Morris
Radiation therapy (RT) activates an in situ vaccine effect when combined with immune checkpoint blockade (ICB), yet this effect may be limited because RT does not fully optimize tumor antigen presentation or fully overcome suppressive mechanisms in the tumor-immune microenvironment. To overcome this, we develop a multifunctional nanoparticle composed of polylysine, iron oxide, and CpG (PIC) to increase tumor antigen presentation, increase the ratio of M1:M2 tumor-associated macrophages, and enhance stimulation of a type I interferon response in conjunction with RT. In syngeneic immunologically “cold” murine tumor models, the combination of RT, PIC, and ICB significantly improves tumor response and overall survival resulting in cure of many mice and consistent activation of tumor-specific immune memory. Combining RT with PIC to elicit a robust in situ vaccine effect presents a simple and readily translatable strategy to potentiate adaptive anti-tumor immunity and augment response to ICB or potentially other immunotherapies.